PureTech Health Statistics
Total Valuation
PureTech Health has a market cap or net worth of $423.59 million. The enterprise value is $182.42 million.
Important Dates
The last earnings date was Wednesday, April 30, 2025, before market open.
| Earnings Date | Apr 30, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
PureTech Health has 240.19 million shares outstanding. The number of shares has decreased by -7.34% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 240.19M |
| Shares Change (YoY) | -7.34% |
| Shares Change (QoQ) | -10.11% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 164.85M |
Valuation Ratios
The trailing PE ratio is 7.92.
| PE Ratio | 7.92 |
| Forward PE | n/a |
| PS Ratio | 87.74 |
| Forward PS | n/a |
| PB Ratio | 1.04 |
| P/TBV Ratio | 1.02 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | 3.41 |
| EV / Sales | 37.78 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.33, with a Debt / Equity ratio of 0.41.
| Current Ratio | 9.33 |
| Quick Ratio | 9.19 |
| Debt / Equity | 0.41 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -13.54 |
Financial Efficiency
Return on equity (ROE) is 6.41% and return on invested capital (ROIC) is -14.55%.
| Return on Equity (ROE) | 6.41% |
| Return on Assets (ROA) | -13.10% |
| Return on Invested Capital (ROIC) | -14.55% |
| Return on Capital Employed (ROCE) | -24.21% |
| Revenue Per Employee | $86,214 |
| Profits Per Employee | $955,536 |
| Employee Count | 56 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -4.01M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -26.87% in the last 52 weeks. The beta is 0.90, so PureTech Health's price volatility has been similar to the market average.
| Beta (5Y) | 0.90 |
| 52-Week Price Change | -26.87% |
| 50-Day Moving Average | 17.78 |
| 200-Day Moving Average | 19.04 |
| Relative Strength Index (RSI) | 48.72 |
| Average Volume (20 Days) | 4,070 |
Short Selling Information
| Short Interest | 5,148 |
| Short Previous Month | 8,303 |
| Short % of Shares Out | 0.05% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 2.68 |
Income Statement
In the last 12 months, PureTech Health had revenue of $4.83 million and earned $53.51 million in profits. Earnings per share was $0.21.
| Revenue | 4.83M |
| Gross Profit | -64.40M |
| Operating Income | -135.87M |
| Pretax Income | -35.17M |
| Net Income | 53.51M |
| EBITDA | -134.06M |
| EBIT | -135.87M |
| Earnings Per Share (EPS) | $0.21 |
Full Income StatementBalance Sheet
The company has $378.69 million in cash and $165.58 million in debt, giving a net cash position of $213.11 million or $0.89 per share.
| Cash & Cash Equivalents | 378.69M |
| Total Debt | 165.58M |
| Net Cash | 213.11M |
| Net Cash Per Share | $0.89 |
| Equity (Book Value) | 407.93M |
| Book Value Per Share | 1.73 |
| Working Capital | 344.87M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$134.37 million and capital expenditures -$11,000, giving a free cash flow of -$134.38 million.
| Operating Cash Flow | -134.37M |
| Capital Expenditures | -11,000 |
| Free Cash Flow | -134.38M |
| FCF Per Share | -$0.56 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -2,814.19% |
| Pretax Margin | 492.42% |
| Profit Margin | 1,108.33% |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
PureTech Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 7.34% |
| Shareholder Yield | 7.34% |
| Earnings Yield | 12.63% |
| FCF Yield | -31.72% |
Analyst Forecast
The average price target for PureTech Health is $45.00, which is 150.84% higher than the current price. The consensus rating is "Buy".
| Price Target | $45.00 |
| Price Target Difference | 150.84% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
PureTech Health has an Altman Z-Score of 1.88 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.88 |
| Piotroski F-Score | 4 |
